Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech
Get the latest updates from FierceBiotech directly as they happen.
Follow now 338 followers
Latest posts
Last updated about 8 hours ago
City aims to lay foundation for RNAi renaissance with nearly $100M series B
about 8 hours ago
Looking to spark an antibody-like revolution for RNA interference medicines, City Therapeutics...
ADA: Dexcom CGM shows benefit in non-insulin diabetes patients
about 13 hours ago
A Dexcom continuous glucose monitor helped adults with type 2 diabetes not...
Clinical-stage cancer biotech Treeline sees path to public markets via reverse merger
about 13 hours ago
Treeline Biosciences, an under-the-radar cancer company that has raised more than $1...
Resmed snaps up Noctrix Health in $340M sleep tech deal
about 13 hours ago
Resmed has closed its $340 million acquisition of Noctrix Health, picking up...
J&J makes $1B upfront bet on emerging DAC space by netting Firefly Bio
about 14 hours ago
Johnson & Johnson has paid $1 billion upfront to buy itself a...
Incyte inks $2B deal to add Star unit to late-phase constellation and challenge Takeda
about 15 hours ago
Incyte has struck a deal to buy a Star Therapeutics subsidiary for...
GSK pledges £44.5M in near-term for UK biotech to explore cause of liver fibrosis regression
about 15 hours ago
GSK’s latest hepatology partnership is posing a less-asked question—how do you stop...
Biopharma moves to reduce development risk earlier than ever
about 16 hours ago
Tighter capital, higher expectations and evolving regulatory frameworks are reshaping drug development...
Biotech value creation at an inflection point
about 16 hours ago
Capital is tighter and expectations are higher. Hear how biotech leaders must...
How integrated strategy is reshaping biopharma growth
about 16 hours ago
RevHealth CEO Ben Beckley shares how integrated teams are helping biopharma organizations...
Why Execution Excellence Now Defines Biopharma Winners
about 16 hours ago
Strategy matters—but execution separates leaders. Hear how top biopharma teams translate strategy...
Biopharma IPOs: Timing, capital and staying flexible
about 16 hours ago
Regulatory shifts, tight capital and volatile IPO windows are reshaping biopharma strategy...